Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis
- PMID: 32298998
- PMCID: PMC8221366
- DOI: 10.1016/j.drugalcdep.2020.107969
Pharmacodynamic dose effects of oral cannabis ingestion in healthy adults who infrequently use cannabis
Abstract
Background: Prior controlled cannabis research has mostly focused on smoked cannabis and predominantly included frequent cannabis users. Oral cannabis products ("edibles") make up a large and growing segment of the retail cannabis market. This study sought to characterize the pharmacodynamic effects of oral cannabis among infrequent cannabis users.
Methods: Seventeen healthy adults who had not used cannabis for at least 60 days completed four experimental sessions in which they consumed a cannabis-infused brownie that contained 0, 10, 25, or 50 mg THC. Subjective effects, vital signs, cognitive/psychomotor performance, and blood THC concentrations were assessed before and for 8 h after dosing.
Results: Relative to placebo, the 10 mg THC dose produced discriminable subjective drug effects and elevated heart rate but did not alter cognitive/psychomotor performance. The 25 and 50 mg THC doses elicited pronounced subjective effects and markedly impaired cognitive and psychomotor functioning compared with placebo. For all active doses, pharmacodynamic effects did not manifest until 30-60 min after ingestion, and peak effects occurred 1.5-3 h post-administration. Blood THC levels were significantly correlated with some pharmacodynamic drug effects, but were substantially lower than what is typically observed after cannabis inhalation.
Conclusion: Ingestion of oral cannabis dose-dependently altered subjective drug effects and impaired cognitive performance. Unlike inhaled forms of cannabis for which acute effects occur almost immediately, effects of oral cannabis were considerably delayed. In an era of legalization, education about the time course of drug effects for cannabis edibles is needed to facilitate dose titration and reduce acute overdose incidents.
Keywords: Cannabis; Edibles; Marijuana; Oral dosing; Pharmacodynamics; THC.
Copyright © 2020. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest Dr. Vandrey has served as a paid consultant for Zynerba Pharmaceuticals and Canopy Health Innovations Inc., and had received honoraria for serving on the scientific advisory boards of FSD Pharma and Present Life Corporation. The remaining authors have no conflicts of interest to declare.
Figures
References
-
- Allen JA, Davis KC, Duke JC, Nonnemaker JM, Bradfield BR, Farrelly MC, 2017. New product trial, use of edibles, and unexpected highs among marijuana and hashish users In Colorado. Drug Alcohol Depend. 176, 44–47. - PubMed
-
- Casswell S, Marks D, 1973. Cannabis Induced Impairment of performance of a divided attention task. Nature 24, 60–61. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources